Long-term effect of tocilizumab in patients with giant cell arteritis: open-label extension phase of the Giant Cell Arteritis Actemra (GiACTA) trial
John H. Stone, Jian Han, Martin Aringer, Daniël Blockmans, Elisabeth Brouwer, María C. Cid, Bhaskar Dasgupta, Jürgen Rech, Carlo Salvarani, Robert Spiera, Sebastian Unizony, Min Bao
Topics & Concepts
TocilizumabMedicineGiant cell arteritisDiscontinuationPrednisonePrednisolonePlaceboInternal medicineGlucocorticoidAdverse effectRandomized controlled trialClinical trialSurgeryVasculitisPathologyRheumatoid arthritisAlternative medicineDiseaseVasculitis and related conditionsOtitis Media and Relapsing PolychondritisSystemic Sclerosis and Related Diseases